These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 27071734

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
    Gellermann J, Ehrich JH, Querfeld U.
    Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
    [Abstract] [Full Text] [Related]

  • 43. Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443): initial clinical experience.
    Kirklin JK, Bourge RC, Naftel DC, Morrow WR, Deierhoi MH, Kauffman RS, White-Williams C, Nomberg RI, Holman WL, Smith DC.
    J Heart Lung Transplant; 1994 May; 13(3):444-50. PubMed ID: 8061021
    [Abstract] [Full Text] [Related]

  • 44. Pilot study of mycophenolate mofetil for treatment of kidney disease due to congenital urinary tract disorders in children.
    Trachtman H, Christen E, Frank R, Rini J, Palestro C, Perelstein E, Weiss L, Tarapore F, Fortune S, Horowitz J.
    Am J Kidney Dis; 2008 Oct; 52(4):706-15. PubMed ID: 18554762
    [Abstract] [Full Text] [Related]

  • 45. Genetic polymorphisms influence mycophenolate mofetil-related adverse events in pediatric heart transplant patients.
    Ohmann EL, Burckart GJ, Brooks MM, Chen Y, Pravica V, Girnita DM, Zeevi A, Webber SA.
    J Heart Lung Transplant; 2010 May; 29(5):509-16. PubMed ID: 20061166
    [Abstract] [Full Text] [Related]

  • 46. Use of enteric-coated mycophenolate sodium in liver transplant patients with intestinal intolerance caused by mycophenolate mofetil.
    Doria C, Ramirez CB, Frank AM, Vaccino S, Fraser N, Marino IR.
    Clin Transplant; 2009 May; 23(6):882-6. PubMed ID: 19573090
    [Abstract] [Full Text] [Related]

  • 47. Mycophenolate in dermatology.
    Liu V, Mackool BT.
    J Dermatolog Treat; 2003 Dec; 14(4):203-11. PubMed ID: 14660264
    [Abstract] [Full Text] [Related]

  • 48. Induction of rosaceiform dermatitis during treatment of facial inflammatory dermatoses with tacrolimus ointment.
    Antille C, Saurat JH, Lübbe J.
    Arch Dermatol; 2004 Apr; 140(4):457-60. PubMed ID: 15096374
    [Abstract] [Full Text] [Related]

  • 49. Mycophenolate mofetil in children with frequently relapsing nephrotic syndrome: a report from the Southwest Pediatric Nephrology Study Group.
    Hogg RJ, Fitzgibbons L, Bruick J, Bunke M, Ault B, Baqi N, Trachtman H, Swinford R.
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1173-8. PubMed ID: 17699344
    [Abstract] [Full Text] [Related]

  • 50. Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study.
    Owen C, Ngian GS, Elford K, Moore O, Stevens W, Nikpour M, Rabusa C, Proudman S, Roddy J, Zochling J, Hill C, Sturgess A, Tymms K, Youssef P, Sahhar J.
    Clin Exp Rheumatol; 2016 Nov; 34 Suppl 100(5):170-176. PubMed ID: 27049330
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Mycophenolate mofetil for treatment of steroid-refractory acute graft-versus-host disease after pediatric hematopoietic stem cell transplantation.
    Inagaki J, Kodama Y, Fukano R, Noguchi M, Okamura J.
    Pediatr Transplant; 2015 Sep; 19(6):652-8. PubMed ID: 26103520
    [Abstract] [Full Text] [Related]

  • 53. Mycophenolate mofetil: a dermatologic perspective.
    Mydlarski PR.
    Skin Therapy Lett; 2005 Apr; 10(3):1-6. PubMed ID: 15986076
    [Abstract] [Full Text] [Related]

  • 54. Successful treatment of severe refractory atopic dermatitis with mycophenolate mofetil.
    Grundmann-Kollmann M, Korting HC, Behrens S, Leiter U, Krähn G, Kaufmann R, Peter RU, Kerscher M.
    Br J Dermatol; 1999 Jul; 141(1):175-6. PubMed ID: 10417549
    [No Abstract] [Full Text] [Related]

  • 55. Mycophenolate mofetil therapy in a child with Churg-Strauss syndrome.
    Demircin G, Baysun S, Bülbül M, Erdoğan O, Oner A.
    Pediatr Int; 2010 Jun; 52(3):e164-6. PubMed ID: 20723119
    [No Abstract] [Full Text] [Related]

  • 56. [Mycophenolate mofetil after penetrating high risk keratoplasty. A pilot study].
    Reinhard T, Reis A, Kutkuhn B, Voiculescu A, Sundmacher R.
    Klin Monbl Augenheilkd; 1999 Sep; 215(3):201-2. PubMed ID: 10528287
    [Abstract] [Full Text] [Related]

  • 57. Perioral dermatitis.
    Lancet; 1980 Jan 12; 1(8159):75-6. PubMed ID: 6101421
    [No Abstract] [Full Text] [Related]

  • 58. Reversible interstitial lung disease following treatment of atopic dermatitis with mycophenolate mofetil.
    Tull TJ, Toma T, Menagé HP.
    Clin Exp Dermatol; 2016 Aug 12; 41(6):702-3. PubMed ID: 27079159
    [No Abstract] [Full Text] [Related]

  • 59. Gastrointestinal side effects in liver transplant recipients taking enteric-coated mycophenolate sodium vs. mycophenolate mofetil.
    Lopez-Solis R, DeVera M, Steel J, Fedorek S, Sturdevant M, Hughes C, Humar A.
    Clin Transplant; 2014 Jul 12; 28(7):783-8. PubMed ID: 24754682
    [Abstract] [Full Text] [Related]

  • 60. Monitoring of mycophenolate mofetil metabolites in children with nephrotic syndrome and the proposed novel target values of pharmacokinetic parameters.
    Sobiak J, Resztak M, Ostalska-Nowicka D, Zachwieja J, Gąsiorowska K, Piechanowska W, Chrzanowska M.
    Eur J Pharm Sci; 2015 Sep 18; 77():189-96. PubMed ID: 26102431
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.